Functional Neuroimaging to Detect the Neural Signatures of the Unpleasantness of Pain and Effort

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

April 9, 2025

Primary Completion Date

June 30, 2034

Study Completion Date

June 30, 2034

Conditions
Fatigue Syndrome, Chronic
Interventions
DEVICE

Thermal Pain Stimulation

Thermal pain will be administered during fMRI neuroimaging via a thermal stimulation device (Medoc Ltd., Advanced Medical System, Israel; 510K: K052357; K041908; K922052) to examine brain activity corresponding to the experience of this stimulus. This device and associated system carries an FDA 510 (K) clearance.

DEVICE

Physical Effort Stimulation

Physical effort will be administered during fMRI neuroimaging via a hand dynamometer attachment for a physiological monitoring system (BIOPAC Systems, Inc., Goleta, CA, USA) to examine brain activity corresponding to the experience of this stimulus. This device has not received pre-marked approval or 510 (K) clearance by the FDA.

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT06472622 - Functional Neuroimaging to Detect the Neural Signatures of the Unpleasantness of Pain and Effort | Biotech Hunter | Biotech Hunter